Jian Gu Sedem Yener Elias Jaime Porras BUS6900 IP Strategy and Management NOVARTIS GROUP.
Companion Diagnostics for Targeted Cancer Therapies: Current Trends and Future Directions 1 Mark A. Reynolds, Ph.D. SLA Symposia June 11 th, 2013.
Cyberinfrastructure for Regenerative Personalized Medicine: The Vision and Challenges Sangtae Kim
Companion Diagnostics for Targeted Cancer Therapies: Current Trends and Future Directions
HeadHunt Issue 39
Journal For Clinical Studies